Jason Gremillion, MD
Pain Medicine · Baton Rouge, LANPI 1295121200
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,937 of the $18,884 with a category attached, or 63.2%. It is spread thinly across 36 manufacturers, the largest accounting for just 21.7%. Reporting peaked in 2021 at $5,192 and has fallen 76.4% since, to $1,224 in 2025. Among pain medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 361 payments — averaging $52.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$4K
- Nevro Corp.$2K
- Spinal Simplicity, LLC$2K
- Medtronic$2K
- MML US, Inc.$1K
- plus $3K from 30 others
What the payments were for
- Travel & lodging$5,51129%
- Food & beverage$11,93763%
- Education$1,4358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 68 | $4,098 |
| Abbott | 88 | $4,073 |
| Nevro Corp. | 52 | $2,339 |
| Spinal Simplicity, LLC | 6 | $1,983 |
| Medtronic(2 entities) | 22 | $1,643 |
| MML US, Inc. | 11 | $1,449 |
| SPR Therapeutics, Inc | 8 | $443 |
| Saluda Medical Americas, Inc. | 4 | $411 |
| Relievant Medsystems, Inc. | 4 | $279 |
| Averitas Pharma Inc. | 4 | $276 |
| Painteq LLC | 7 | $222 |
| AbbVie(2 entities) | 18 | $214 |
| Collegium Pharmaceutical, Inc. | 13 | $201 |
| Amgen | 11 | $179 |
| Stryker | 3 | $155 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $122 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $92 |
| Almatica Pharma LLC | 5 | $76 |
| Globus Medical | 3 | $63 |
| Novartis | 4 | $60 |
| Scilex Pharmaceuticals Inc. | 3 | $49 |
| Si-bone, Inc. | 1 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| ALON Medical Technology | 1 | $27 |
| Smith+Nephew | 1 | $25 |
| Eisai Inc. | 1 | $25 |
| Avanos Medical | 1 | $23 |
| Tersera Therapeutics LLC | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,037
- HA MINUTEMAN G3-R$1,927
- Intracept$1,152
- ReActiv8$1,132
- Senza Spinal Cord Stimulation System$867
- INTELLIS$797
- SPECTRA WAVEWRITER$729
- Omnia$377
- ETERNA$291
- Proclaim IPG$282
- WaveWriter Alpha Prime 16$265
- Evoke SCS$262
- SPRINT PNS System$238
- SYNCHROMEDII$174
- GENERAL PAIN MANAGEMENT$142
- KYPHON EXPRESS II KYPHOPAK TRAY$134
- Evoke$127
- NEXLIZET$125
- NEXLETOL$125
- VERTIFLEX SUPERION$125
How this compares
$18,884 in reported general payments places this provider in the 90th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 629 | $6,723 |
| Gabapentin | 377 | $5,585 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 236 | $2,930 |
| Tizanidine Hcl | 246 | $1,973 |
| Lidocaine | 21 | $1,700 |
| Methocarbamol | 154 | $1,623 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 103 | $1,556 |
| Tramadol Hcl | 241 | $781 |
| Celecoxib | 24 | $589 |
| Duloxetine Hcl | 41 | $556 |
| Oxycodone Hcl | 17 | $500 |
| Nabumetone | 75 | $466 |
| Diclofenac Sodium | 31 | $435 |
| Baclofen | 64 | $434 |
| Topiramate | 80 | $401 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Baton Rouge
- Barrett JohnstonBaton Rouge$14K
- Samir PatelBaton Rouge$11K
- Samita DasBaton Rouge$10K
- Andrew BarkerBaton Rouge$9K
- Jake TrahanBaton Rouge$9K
- William GraugnardBaton Rouge$7K
- Paul KrammBaton Rouge$5K
- Jyoti PhamBaton Rouge$4K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.